复星医药(02196)完成发行2025年度第二期科技创新债券

Group 1 - The company, Fosun Pharma, has completed the issuance of its second phase of technology innovation bonds for the year 2025, under the registered quota [1] - The bonds are named "25 Fosun Pharma MTN002" and are categorized as technology innovation bonds [1] - The total amount issued is RMB 1 billion, with a maturity period of 2 years and an issuance interest rate of 2.70% [1]